Find your next paid study

University of MiamiNCT06952790

~$10 – $750

Actual pay is set by the research site.

Phase 2

Multi-centre, Open-label Trial to Assess the saFety, Pharmacodynamics, Efficacy and Pharmacokinetics of pegunigaLsidase Alfa in Patients From 2 Years to Less Than 18 Years of Age With Confirmed FabrY Disease

A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents with Fabry Disease.

Fabry Disease

Chiesi Farmaceutici S.p.A.NCT06328608

~$75 – $3,000

Actual pay is set by the research site.

HIVMental Health DisorderSubstance Use

Enhancing Wellness Through Affirming Services and Education

The goal of this treatment study is to learn about the mental health, substance use and physical health outcomes associated with participating in the EASE holi…

Duke UniversityNCT05700474

~$10 – $750

Actual pay is set by the research site.

Circadian RhythmPupillometrySleep

Documenting Relationships Among Pupil Responses to Light, Circadian Rhythms, and Sleep in Healthy People and Those With Disorders or Disease

The investigators are studying relationships among eye pathology, pupil responses to light, sleep, circadian rhythms, and hormones in healthy individuals and t…

Elizabeth B Klerman MD PhDNCT07753889

~$10 – $1,125

Actual pay is set by the research site.

SchizophreniaSchizo Affective Disorder

Cromoglicte Adjunctive Therapy for Outpatients With Schizophrenia

This is a double blind adjunctive randomized controlled trial for schizophrenia using cromoglicate.

Vishwajit Nimgaonkar, MD PhDNCT03794076

~$150 – $4,500

Actual pay is set by the research site.

Atrial FibrillationCOVID-19Cancer+1 more

Preliminary Evaluation of [64Cu]FBP8 in Healthy Individuals and Subjects With Known or at Risk of Developing Thrombosis

The purpose of the study is to evaluate a new radiotracer called 64Cu-FBP8 for PET-MR imaging of thrombosis. The tracer has the potential of detecting thrombos…

Massachusetts General HospitalNCT03830320

~$500 – $7,500

Actual pay is set by the research site.

CancerSurvivorshipAnxiety

Online Training After Cancer (On-Trac): Developing An Online Intervention for Cancer Survivors Managing Anxiety

This study is evaluating On-Trac (Online Training After Cancer), an online educational intervention to teach adult cancer survivors strategies to address anxie…

Documented

Up to $90

Dana-Farber Cancer InstituteNCT07305740

Small Cell Lung Cancer Extensive StageBrain MetastasesSolid Tumor, Adult+3 more

Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM): A Multi-cohort Platform Trial of Adaptive Radiotherapy Approaches in Multiple Cancer Types

To characterize feasibility, safety, and/or preliminary efficacy of personalized strategies to adapt standard radiotherapy treatments to individual patient res…

University of Texas Southwestern Medical CenterNCT07139990

~$150 – $3,000

Actual pay is set by the research site.

Dystrophic Epidermolysis Bullosa

Mesenchymal Stem Cell Extracellular Vesicles for the Treatment of Recessive Dystrophic Epidermolysis Bullosa Wounds

INVESTIGATIONAL PRODUCT: AGLE-102 is an allogeneic extracellular vesicle (EV) product derived from normal donor mesenchymal stem cells (MSCs). INDICATION AND …

Aegle TherapeuticsNCT04173650

~$150 – $4,200

Actual pay is set by the research site.

A Long-Term Follow-Up Study of Subjects Completing the AU-011-301 (CoMpass) Trial of Bel-sar for Early Choroidal Melanoma (Indeterminate Lesions/Small Choroidal Melanomas)

AU-011-403 is a multicenter long-term follow-up safety and efficacy study of subjects with early CM who previously participated in the AU-011-301 Phase 3 trial…

Choroidal MelanomaIndeterminate Lesions

Aura BiosciencesNCT07338968

~$10 – $1,050

Actual pay is set by the research site.

Diffuse Midline Glioma, H3 K27M-MutantRecurrent High Grade Glioma

Phase I Trial: CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy With Adjuvant Reirradiation for Recurrent High-Grade Glioma and Newly Diagnosed Diffuse Midline Glioma/Diffuse Intrinsic Pontine Glioma in Children and Young Adults

This is a single center Phase I study of a new adjuvant CD200 activation receptor ligand, CD200AR-L, in combination with imiquimod and GBM6-AD vaccine to treat…

OX2 TherapeuticsNCT06305910

~$150 – $4,200

Actual pay is set by the research site.

Ifluence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effect

To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (…

Smoking Behaviors